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Abstract
Background: Tuberculosis is a major public health problem in Myanmar as in other developing
countries. About 73% of TB patients seek care at private general practitioners' clinics before
presenting to the public TB centre, raising questions about how best to prevent transmission and
maintain treatment regimens.
Method: The study was conducted in two townships in Yangon Division in Myanmar in 2004, and
examined treatment seeking behaviour of TB patients and their views towards public and private
health care services. This was an exploratory descriptive study. Both quantitative and qualitative
research methods were employed in data collection from TB patients, health care professionals,
and members of various agencies involved in TB Control Programme.
Results: A considerable delay was found between the onset of symptoms of TB and seeking
treatment (five days – two months). General practitioners were the first point of contact in all
cases. Old TB patients influenced the treatment seeking behaviour and choice of treatment clinics
of new TB patients. Most patients viewed the public health sector as a place to obtain free
treatment and the private sector as a fee-paying, convenient and better place to seek treatment.
Conclusion: The involvement of private general practitioners is crucial for effective TB control in
Myanmar. The selection of GPs for partnership with the public sector is vital to the success of
public-private partnership in controlling TB.
Background
Increasing emphasis has been placed in recent years on
public-private partnerships in the health sector, in recog-
nition of the current distribution of services and patient
choices and preferences, and to support the efficient and
effective delivery of health services. Health care provision
is considered conventionally to be the responsibility of
the public sector and government in developing coun-
tries, as reflected in the Alma Ata Health Declaration and
other key global mission statements [1]. However, by the
mid 1980s, the role of government in health care provi-
sion had changed [2], with the World Bank recommend-
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ing a reduction in the level of government involvement in
health care and promoting investment from the private
sector. The WHO held a series of meetings from 1990,
focusing on the role of the private sector [3-5], and in
developing countries, public-private partnerships began
to be adopted especially in areas of high need – reproduc-
tive health care, diarrhoea, malaria, HIV, sexually trans-
mitted infections (STI) and TB. Many largely inter-related
circumstances worked to support the initiation of public-
private partnerships (PPP) in developing countries. These
included: political and economic changes; the introduc-
tion of an open market economy; increased demand by
the general public for quality services; health sector
reform; limited resources in the public sector; an
increased proportion of public staff working also in the
private sector; the development and the increased involve-
ment of non-government organizations (NGOs) in health
care services; urbanization and diversity of health care
providers in peri-urban and slum areas; and poor or sub-
standard practices in the private sector.
In developing countries such as Myanmar, privatization
was widespread as an unplanned response to the failure of
the public sector [2]. Limited human resources and funds
in the public sector had led to poor public health services
and reduced quality of care especially, but concurrently,
the government had not anticipated an increased demand
for high technical quality of care and so had no guidelines
to interact with the private sector. The support of a market
economy and increased demand for quality health care
led to an overgrowth of the private sector for infectious as
well as non-communicable disease. This included TB, the
control of which involves prompt and correct diagnosis
and firm adherence to treatment. A series of operational
research studies, conducted by the WHO in India, Nepal,
Vietnam, Indonesia and Myanmar, confirmed that the pri-
vate sector was the dominant diagnostic resource even for
poor patients [5]. In most member countries in the WHO
South-East Asia region, private general practitioners (GPs)
manage more than half of all  tuberculosis patients,
despite the fact that diagnostic services, appropriate med-
ication, and monitoring to ensure adherence appear to be
ineffective in this sector [6-11].
Myanmar is one of 22 countries globally regarded as hav-
ing a high burden of TB [12]. According to the National
Surveillance Reports produced by the National Tuberculo-
sis Programme in Myanmar, tuberculosis is the fifth lead-
ing cause of morbidity and second leading cause of
mortality, mainly affecting those in the most productive
age groups (15–59) [13]. Annually, an estimated 1.5% of
the population is infected with TB, and about 85,000 peo-
ple progress to develop the disease [14]. In the National
Health Plan (NHP 2001–2006), TB is ranked as the third
priority disease following HIV/AIDS and malaria. Since
2000, the WHO has encouraged its implementation of
public-private partnership projects to improve TB control,
and in 2003, the Myanmar Ministry of Health developed
guidelines to involve private general practitioners (GPs)
in the National Tuberculosis Programme (NTP) [15].
Hence a public-private partnership was initiated,
although as elsewhere, there has been limited scholarly
attention to the factors that support or discourage its suc-
cessful implementation and/or sustainability. To find out
effective strategies for public-private partnerships, it is
important and necessary to take account of both health
providers' and patients' perspectives of public and private
health care services. In this article, we describe TB patients'
preferences and underlying reasons for choosing treat-
ment centres, and analyse their views on public and pri-
vate health care services.
Health Services in Myanmar
Health care and medical services in Myanmar are pro-
vided by both the public and the private sectors. The pub-
lic sector, which includes hospitals, diagnostic services,
outpatient clinics and primary health care programs, is
managed by the national Ministry of Health. The National
Tuberculosis Programme (NTP) of the Ministry carries out
TB control activities through Township Health Depart-
ments (THD) that operate in all 325 Townships in the
country. The Township is the unit of management for all
disease control activities and is responsible for providing
primary health care to an average population of 130,000.
The THD provides a laboratory service for sputum micro-
scopy, registers and records TB cases (excluding those reg-
istered with private practitioners), maintains drug storage
and consistent supplies, and provides anti-TB drugs to
patients according to a standardized regimen. THD staff
also follow-up people with TB, provide health education
to patients and to a lesser extent the community, accord-
ing to NTP guidelines, and report to the NTP regularly.
In principle, microscopy services for sputum examination
are available at the THD, but in many townships this is
not the case, and patients may have to visit a District, State
or Divisional TB Centre for a sputum examination. One
sputum microscopy centre is available per 100,000 peo-
ple, half of the ideal standard (1: 50,000). Although some
midwives have been trained to collect sputum from
patients and to send the sample to the district laboratory,
patients often have to travel themselves to a district-level
TB centre for sputum examination for diagnosis, evalua-
tion and monitoring.
The private sector includes various individuals and insti-
tutions, including international and local non-govern-
ment organizations (NGOs), private general practitioners,
private hospitals, private pharmacies, small stationery and
basic provision stores stocking medicines, and traditionalHealth Research Policy and Systems 2009, 7:19 http://www.health-policy-systems.com/content/7/1/19
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practitioners. Private GPs have usually trained as general
physicians or family medical doctors, but they are a
diverse group. They include physicians who are employed
in government service but who take private patients out-
side of office hours, and GPs engaged only in private prac-
tice. They also include GPs working in private capacity but
registered with an international non-governmental organ-
ization (INGO), Population Services International (PSI).
As this illustrates, both public-employed and salaried doc-
tors, whether or not they work as doctors in this context,
and private doctors who charge consultation fees, run
their own private clinics. Most private clinics are open in
the evenings; in contrast, government clinics operate from
9 am to 4 pm. At the time of the study, PSI was the only
INGO involved in PPP and able to provide free anti-TB
drugs, so extending its original role to train GPs to provide
reproductive health care (PSI is referred to as INGO in this
paper). The Myanmar Medical Association (MMA) also
trained GPs for TB control, but at time of the study, it was
only involved in encouraging GPs to refer patients to pub-
lic centres for TB control and to provide health education.
In general, patients in Myanmar prefer to seek care at a GP
clinic first irrespective of their socioeconomic status
because of their convenient opening hours and their prox-
imity to patients' residences, and the ability of GPs to pro-
vide individualized care. However, there is no
documented study on the utilization patterns of public
and private health care services in Myanmar. We know lit-
tle about people's selection of a treatment centre for tuber-
culosis in Myanmar, and there has been limited work on
choice of treatment centres for TB patients [16]. One
social science study on the burden of TB, and a quantita-
tive study on treatment seeking of TB patient [17-19],
showed that 73.3% of TB patients sought care at GP clinics
in preference to a public facility as first action in treatment
seeking. In addition, a pilot study in Kyauk Se Township,
conducted by Department of Medical Research (Upper
Myanmar) in collaboration with the Myanmar Medical
Association (MMA) and the National Tuberculosis Pro-
gramme (NTP), illustrated the value of involving private
GPs in TB control: Private GPs contributed 44% of new
smear positive cases registered over a two-year period
(2002 to 2004) [20]. The notification of new sputum
smear-positive TB in this Township increased by 85%
from 46 to 85/100 000 from July 2002, the year prior to
GP involvement, to December 2004 (2 years later). The
treatment success rate for new smear-positive cases treated
by GPs was 90%, leading the authors to conclude that the
involvement of private GPs substantially increased TB
case notification and maintained a high treatment success
rate [20].
The present study on TB patients' treatment seeking pref-
erences was undertaken to explore their reasons for choos-
ing treatment centres, and to elicit their views on public
and private health care services in Yangon.
Methods
Study design
The study reported in this paper is part of a larger study
that was conducted with the aim of exploring how the
public-private partnership currently operates in Myanmar,
identifying constraints to efficient and effective opera-
tions of the partnership, and on this basis identifying pos-
sible strategies to improve public-private partnership in
Myanmar. Both qualitative and quantitative methods
were used in data collection. In this paper we report only
the qualitative aspects of the study, which used explora-
tory descriptive methods, particularly, face-to-face inter-
views. In-depth interviews were conducted with TB
patients who had presented to and were being treated by
doctors in the public sector (i.e. through the Township
Health Department) and who were being treated in the
private sector, through GP clinics, in Yangon. Twenty key
informant interviews with National Tuberculosis Pro-
gramme staff and TB coordinators from Township Health
Departments were conducted. Qualitative methods ena-
bled the exploration of complex areas not amenable to
quantitative research [21-23].
Study area
Yangon Division is located in south or lower Myanmar. It
has a population of 6,187,685, including residents of the
capital city, Yangon, and 45 townships situated in the
Division. Since Yangon is the capital city, private sector
involvement in health services and the provision of care is
quite high. Private GP clinics are particularly abundant,
with about 50 to 100 GP clinics in an urban township
(with a population of 50,000 to 200,000) compared with
only about three to five in a village tract.
For the study from which we draw, two townships in Yan-
gon Division were selected on the basis of the following
criteria: that a Township Medical Officer acted as a TB
team leader, there was a District TB team or NTP staff
responsible for TB control, and the townships were
located in peri-urban areas of Yangon.
Data collection
Both female and male TB patients (21 male, 10 female)
were recruited from the THD and GP clinics for inclusion
in the study on a continuing basis, without specific selec-
tion criteria other than age ≥ 18 years. All registered TB
patients who were under treatment (that is, both new and
old TB patients) were included. We did not specifically
choose old or new TB cases, but as interviews progressed
our analyses showed that some of the interviewees had TB
previously (hence we classified them as 'old cases') and
patients who contracted TB for the first time were classi-Health Research Policy and Systems 2009, 7:19 http://www.health-policy-systems.com/content/7/1/19
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fied as 'new cases.' Since we were exploring TB patients
health seeking behaviour specifically – which incidentally
was very similar for both groups of patients – we did not
treat them as separate group for analytical purposes. The
pathway for old or new cases had common elements and
we were interested in exploring these further.
TB patients were recruited through receptionists from the
THDs and all three categories of GP clinics – (a) GPs
employed in government service part-time and saw patients
privately outside of office hours, (b) GPs engaged only in pri-
vate practice, and (c) GPs working in collaboration with the
INGO involved in TB care in Yangon. In Myanmar, most GP
clinics do not have receptionists or assistants. It was not pos-
sible to recruit from the waiting area because of privacy and
confidentiality issues. We had no knowledge of patients' TB
status, as we could not access patients' register or records
without their consent. Enlisting the attending GP's help was
the only recourse we had to recruit patients for in-depth
interviews. GPs were instructed not to advise patients nor
coerce them to participate in the study, but to provide gen-
eral information and to suggest to them that, if interested,
they contact the researcher.
Recruitment continued until the diversity of experience
was identified and understood [24], i.e., no new informa-
tion was emerging from the interviews after initial analy-
sis of the data, or from later complete analysis which was
conducted in the field. As we reached data saturation with
31 patients, i.e., we did not obtain any new additional
information, we did not recruit any more patients for in-
depth interviews. Interviews were based on a pre-tested
interview guide. The interviews lasted for about one hour
to 90 minutes.
An interview guide was used and interviews were tape
recorded with the permission of interviewees. All inter-
views were conducted in Burmese by SS. Each person was
interviewed once only. During data collection, emerging
issues were identified that were explored in subsequent
interviews. Reflexive notes and field observation notes
were also made (by SS and MB) to assist in the interpreta-
tion of qualitative data.
Data analysis
The main themes for interviews were derived from the
study objectives to explore reasons for choosing private or
public and patients' views on public and private health
services in Myanmar. Hence the semi-structured in-depth
interview guide covered three main themes – treatment
seeking, choice of treatment (public or private), and opin-
ions and suggestions related to the public-private partner-
ship.
The interviews were transcribed and organized on the
basis of emerging themes and sub-themes. SS transcribed
and read over the transcripts to identify primary themes,
from the interview guide and from the data before organ-
izing data with ATLAS ti (version 5) software. Main
themes and emerging themes, and their relationship to
each other, were explored, and the inter-relationship of
themes was summarized for discussion with the other
authors. Sixty five codes were identified; some codes were
merged after detailed analysis. Primary code families were
organized and linkages and relations among codes and
code families were observed. This facilitated the analysis
and interpretation of the qualitative data.
Ethics
Prior to conducting this study, we acquired ethical clear-
ance from relevant institutes including the Ethical Com-
mittee on Medical Research involving Human Subjects
from the Department of Medical Research, Lower Myan-
mar; the Research Ethics Review Committee from the
World Health Organization, Geneva; and the Human
Research Ethics Committee from The University of Mel-
bourne. The participants (BHS, NTP staff and GPs) were
de-identified and were assigned a number, and quotes are
attributed on this basis (e.g. BHS 1, NTP staff 1, GP 1). In
quoting patients, gender, age and treatment centre (THD
or GP clinic) are used for identification: For instance, a 28-
year-old man who was receiving treatment at the PSI GP
clinic is identified as "M 28 treated at PSI GP clinic."
Results
As noted above, 21 male and 10 female patients were
recruited, reflecting patient distribution in Myanmar
(2:1). The ages of respondents ranged from 24 to 78 years
(mean = 41 years). Almost all respondents were labourers,
although a few were university students, unemployed or
otherwise not in the paid workforce. Fourteen patients
were seeking care at the Township Health Department
(public sector) and the remaining 17 were seeking care
from GPs at time of interview.
Treatment seeking behaviour
New patients reported that they were motivated and
encouraged by former patients, who they knew had been
cured of the disease. Former TB patients, including rela-
tives, friends and neighbours of newer patients, provided
information on diagnosis and treatment, advising them to
seek care in the public health sector or from a private GP
clinic where free treatment was available. A few patients
were advised to go to public sector by a local administra-
tive officer or an employee of the urban health centre.
Township Health Department and INGO GP clinics were
the most common places of referral by former patients.
The most common pattern of treatment seeking is shown
in Figure 1. Although almost all TB patients sought health
care treatment at GP clinics first, most had already used
herbal medicine or other home remedies to relieve cough-Health Research Policy and Systems 2009, 7:19 http://www.health-policy-systems.com/content/7/1/19
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ing symptoms. Twenty four out of 31 patients took medi-
cine at home before seeking care at GP clinics or public
sector. Almost half of them tried traditional medicine to
relieve cough and fever. Close relatives suggested different
kinds of home remedies and herbs. Eight patients stated
that they tried western medicine such as paracetamol,
cough syrup, cold tablets and other antipyretics. One
patient revealed that he had bought an over-the-counter
anti-TB drug (AKT-4, a combination of Rifampicin, Isoni-
azid, Ethambutol and Pyrazinamide) at a drug store and
had self-medicated. He had contracted TB four times. A
few patients took both western and traditional medicines
at home. There was a wide range in the duration reported
by study participants of taking home treatment, from 2–3
days to one year:
At first, I though I had flu. So, I took some western
medicine like Biogesic for a week. I took Aung Ta Man
(traditional medicine for fever, packed in powder
form) too. Usually, I get relief after taking a couple of
packets. But this time, there was no relief after a few
days. Then I went to see the GP. (M 41 treated at THD)
Table 1 shows the steps taken by 25 patients who first
sought care outside the home at GP clinics, before labora-
tory-confirmed diagnosis with TB. Of the remaining six,
one went straight to the TB centre, Yangon Division, four
went to a specialist clinic and one went to the Township
Health Department.
Eight participants continued to take treatment at the GP
clinic at which they first presented. The rest (23 out of 31)
sought care at more than one clinic because symptoms
were not relieved by the treatment prescribed at the first
clinic. A few patients (3 out of 31) were hospitalized and
after discharge were referred to the THD. It was also quite
Treatment seeking among TB patients Figure 1
Treatment seeking among TB patients.
Legend 
Most common pathway of treatment seeking  
General referral pathway 
Other treatment seeking pathway  
Other referral pathway 
Note:  Two way arrows indicate referrals both to and from the Yangon Division TB Centre, 
THD and public hospitals.Health Research Policy and Systems 2009, 7:19 http://www.health-policy-systems.com/content/7/1/19
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common for TB patients to consult with a number of
health care providers during the course of their illness.
The main reason for switching from one clinic to another
was because they felt that they were getting no relief from
persisting symptoms.
I was coughing for about 20 days and had fever for 15
days. I ignored it and did not take any care or treat-
ment for this condition. But, I had no appetite and was
losing weight. Then I went to an inn-galaik say-khan
(western medical clinic), the doctor said that my lungs
were bloated. I took treatment there for three days and
took my medication regularly, but I was still coughing.
Since the treatment was not effective I went to another
GP clinic and again took treatment there for three
days.
Unfortunately, my symptoms were still persisting, and
I lost a huge amount of weight. So I rested at home for
about four to five days without seeking any treatment
from any clinic. At that time, my sister-in-law visited
me and said that she suspected TB, because when she
contracted TB, she too felt the same. She advised me to
go and seek care at Aung San [TB Centre, Yangon Divi-
sion]. Finally I went there and was diagnosed with TB.
(F 44 treated at THD)
The main reason for switching from GP clinics to the pub-
lic sector was the financial constraints associated with
long-term treatment. The average consultation fee per visit
at GP clinic is about 3000 kyats (US $3) and the cost for
anti-TB drugs is also 3000 kyats per day. Cost of anti-TB
drugs for the full course (i.e. six months) is 84,000 kyats
(US $840). While patients need to purchase drugs and pay
consultation fees at GP clinics, TB treatment is available
free in the public sector, including from both the TB Cen-
tre and the Township Health Departments. Most patients
got anti-TB drugs from the Township Health Department
(THD) and consulted with their respective GPs to relieve
other symptoms of TB, with some patients sought treat-
ment from both the private and public sector simultane-
ously. This is well illustrated by a 55-year-old participant
taking treatment at the THD.
When I got fever, I went to the GP clinic in my ward.
Sayama  (lady GP) told me that I got asoak pwa
(inflamed lungs) and then prescribed drugs. She did
not tell me that it was TB. I took the drugs for 16 days.
Afterwards, I sought care at another GP since the
symptoms were not relieved. The second GP was lung
specialist. He told me that I had not contracted TB.
Then I stopped taking treatment. After a couple of
months, I coughed with blood. So, I went to a third GP
clinic where I am currently taking treatment. (M 54
treated at GP clinic)
The finding – that patients prefer the GPs to whom they
usually present but finally end up at THD for economic
reasons – is consistent with the findings from in-depth
interviews with GPs and BHS:
When we refer, few patients refuse to go to the THD.
We have to explain that drugs are provided for free,
and more effective treatment is available at THD,
etc....Even then, they prefer their family GP...TB
mainly affects the poor and they cannot afford long
term treatment at private GP clinics. So I always refer
my patients to THD (In-service GP 2).
Public and/or private care?
The international NGOs, Population Service International
(PSI), as noted above, has been involved in TB control in
collaboration with the NTP since 2003. According to the
Memorandum of Understanding (MOU) between the
Table 1: Treatment seeking behaviour before diagnosis with TB
Order Domain and strategy Purpose and action
1 Home treatment Trial with home remedies and herbs
2 Self-medication Use of western and traditional medicines from over-the-counter stores
3 Sought advice from friends and relatives Advice from friends and relatives influenced treatment seeking patterns and 
choice of treatment centre. Old TB cases provide advice informally to new TB 
cases
4 Seeking treatment from GPs as first formal source All patients first sought care at GP clinics
5 Shopping around treatment centres Some patients opted to see different GPs and specialist clinics when symptoms 
did not subside. Some patients sought care at more than one treatment centre.
6 Seeking care from public health service Patients went to public health service when their symptoms did not improved 
after seeing many GPs or when they suspected themselves of contracting TBHealth Research Policy and Systems 2009, 7:19 http://www.health-policy-systems.com/content/7/1/19
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Ministry of Health and PSI, a PSI GP can charge a consul-
tation fee of 300 kyats (US$ 0.30) for one visit, but anti-TB
drugs have to be given free. At the time of the study, three
INGO clinics operated in both study townships, provid-
ing health care services for reproductive health and sexu-
ally transmitted diseases, TB treatment and general family
medicine. Among those taking treatment at outpatient
clinics at THD (13), five indicated their preference also to
go to GP clinics. All patients receiving treatment at INGO
GP clinics reported that they were satisfied with the serv-
ice; these people all had prior experience of attending
INGO clinics for minor ailments. Therefore, once diag-
nosed with TB, they elected to receive treatment from
these clinics rather than going to the public clinic or
attending their own, fee-for-service, GP. However, all
patients (18) who were treated at GP clinics stated that
they preferred their family doctors (GPs), even when their
GPs were not affiliated with the INGO and so were unable
to provide free anti-TB drugs; despite the costs, they pre-
ferred this option for as long as they could afford to do so,
because of their familiarity with and trust in their pro-
vider.
A fuller exploration of choice of treatment centre indi-
cated that preferences are related in part to distance from
home and/or workplace, opportunities to ask questions
and to receive clarification, the ability to receive concur-
rent treatment for other diseases such as Diabetes Melli-
tus, prior acquaintance with the GP, and cost (hence the
choice of PSI clinics). Patients receiving treatment at GP
clinics and those at the THD had similar views on the pub-
lic health care service in terms of opening hours, long
waiting times and complicated procedures: A few patients
also mentioned the inconvenience of paper work at THD
that was necessary for them to get free treatment, and for
this reason, they switched to a GP clinic. Some patients
were seeking care for TB at more than one centre, but there
was no communication between GP clinics and the THD
to establish which patients were receiving treatment from
more than one clinic.
I do not go to the Township Health Department
because it would take too much time. For us, time is
money. I have to work for my day-to-day living and
cannot spare working hours to attend THD. (M 32
treated at GP clinic)
If the cost of treatment were the same, I would go to a
GP clinic, because it's more convenient for me. It's
close to my home and I could go in the evenings. (F 33
treated at THD)
Some patients regarded THD as a high-risk public place,
too, where one could contract severe infections from oth-
ers. Participants described THD as overcrowded, with dark
and narrow spaces where they could easily get infected. A
few patients pointed out that they were afraid that if their
relatives were to accompany them, they would contract TB
from other severely ill patients at the THD. These ideas of
risk, contagion and stigma, that inhibited people from
reporting disease and influenced family and community
interactions, were widely held:
At Township Health Department, if there are a few
patients, it is convenient and you don't have to wait
too long. But if there is a long queue, I worry that we
might contract severe disease from others while we're
waiting there. All sorts of severe cases are mixed up in
the crowd. (F 42 treated at GP clinic)
Yet much of the reasoning by patients was contradictory.
In both townships, THDs are close to residential areas and
can be reached by bus within a half an hour. Although
most patients receiving treatment at the THD stated that
they did not have any problems of access, all of them had
visited a GP clinic first. When cost became a major con-
cern for those requiring long-term treatment, patients
switched to THD where they could get free drugs. There is
considerable uncertainty and distrust by patients about
GP's willingness to provide free treatment at their clinics.
Most patients saw GP clinics as a commercial venture – a
place to pay – and the THD as a place where they could get
free treatment, as illustrate below:
What do you think about collaboration between GP clinics
and the public sector like THD?
Well, GP clinics are for well-off people. You don't have
to wait for long there whereas we have to wait at THD.
But it's free at THD and I don't think we can get free
drugs at GP clinics.
What if the government were to distribute drugs free to GP
clinics?
(Laughing) It's hard to say. If the government forces
GPs to provide free drugs, that may be possible, I sup-
pose. It depends on individual doctors, I would say.
Some GPs wouldn't be able to do so and might have
to charge for drugs. It would be hard for patients if the
GP were to ask for money. I think our Sayama (the lady
GP) could collaborate with THD. She is kind; also she
lives in our suburb and is close to and friendly with all
of us. However, there are different kinds of people
(working as GPs). Some may not want to be bothered
with (TB) patients. Moreover, some people might be
reluctant to go to a GP clinic for free treatment,
because GP clinics are regarded as places where you
have to pay to get treatment. (F 26 treated at GP clinic)
The best thing is to provide free drugs through GP clin-
ics that are convenient for patients. Then, time andHealth Research Policy and Systems 2009, 7:19 http://www.health-policy-systems.com/content/7/1/19
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money can be saved. Yet it depends on the individual
GP – how much he or she would contribute in terms
of their time. (M 55 treated at GP clinic)
Patients receiving treatment at GP clinics had a different
view of their family GP and other GPs. They trusted their
own GPs to provide free drugs if the drugs were supplied
by the public sector. However, they indicated that the con-
tribution by GPs to TB control would depend on the indi-
vidual GP. According to patients, some GPs might not be
interested or willing to collaborate with the public sector,
for financial or other reasons. Most patients stated that it
would be more convenient for patients if they could get
free treatment from any GP clinic, but they felt it neither
realistic nor practical to expect all GPs to collaborate.
It would be great if anti-TB drugs were distributed to
all GP clinics. But, I'm only sure about our Saya (the
GP), who is very kind and good towards his patients,
you know. It mainly depends on the individual,
whether he would give free treatment or not. (F 23
treated at one of the INGO GP clinic)
I think it is possible to distribute free drugs through all
GPs in our suburb. But, I don't think specialist clinics
would do so. Specialist clinics are always busy and
hunting for money. Therefore, providing free drugs
and specialist clinics are like east and west. (F 26
treated at GP clinic)
Some patients mentioned that GPs would not be willing
to contribute unless they were obliged to do so; they felt
that some GPs would be reluctant to spend clinic hours
with TB patients without being paid. A few also pointed
out that collaborations between public and private were
not sustainable because GPs were not responsible for pro-
viding public health services such as providing free treat-
ment to TB patients. However, all patients agreed that a
public-private partnership was a good idea and would
benefit them:
Collaborations between GP clinics and THD are not
always easy in the long run. It would be good if a GP
has cetanar (good will) towards patients. Public staff
have the responsibility of taking care of TB patients,
and they are obliged to provide care, whereas GPs have
no obligation. I think that if GPs do not get any benefit
from it in the long run, they'll be disappointed and
will pull out from collaboration. (M 42 treated at
THD)
Conclusion
Participants reported considerable delay between the
onset of symptoms of TB and seeking treatment. Few
regarded cough alone as a serious symptom warranting
medical attention, and so did not suspect TB initially.
Once diagnosed, although all study participants were
aware that they could get free treatment in the public sec-
tor and viewed this positively, a number opted to seek care
at a private GP clinic, at least in the short term. Consistent
with findings from other studies conducted in the South
East Asia region, the GP was the first point of contact for
all patients [25-27]. Cost was a significant reason for
switching to or consulting with public providers, espe-
cially because TB is known as requiring long-term treat-
ment. Although all patients sought care at GP clinics first,
they had little confidence and/or trust in GPs to give them
free treatment. The participants viewed GP clinics as
places at which they would have to pay for services, and
saw the THD and public health care services as the appro-
priate places to get free treatment. As cost was a major con-
cern for most study respondents, their preference for
private health care is not easily interpreted. Further,
among those who were receiving treatment at the THD, a
number indicated that if the cost were the same, they
would prefer to see a GP. Common elements were
observed in health seeking behaviour pattern amongst the
study population irrespective of age, geography, or pov-
erty.
The reluctance of participants to attend the THD for any
reason other than access to free drugs, and the preference
to remain in the care of their own family practitioner
rather than an INGO GP or the THD, highlight the poten-
tial for and difficulties associated with public-private part-
nerships. We did not explore whether there was a
difference in adherence to treatment and successful cure,
according to provider and attitude to services. The
strength of views and preferences suggest, however, that
access to and relationships with providers may be signifi-
cant in the effectiveness of TB treatment, indicating that
selection of providers in PPP is crucial for the pro-
gramme's success. On the basis of this study, the NTP and
MMA have identified specific selection criteria for GP
involvement in PPP:
1. Providers who have many TB patients under their care
(on the presumption that patients will prefer to see that
specific provider); and
2. Providers who diagnose and treat TB patients provide
free TB drugs and follow-up patients.
It is too soon to comment on the feasibility of the PPP
programme as it is still in its infancy.
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